KI 30606
Latest Information Update: 30 May 2001
At a glance
- Originator Il-Yang; Nonindustrial source
- Class Antineoplastics; Platinum complexes
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 08 Sep 1998 Profile reviewed
- 08 Sep 1998 No-Development-Reported for Cancer in South Korea (Unknown route)